Plain-English translation of NCT06324188 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Atrial Fibrillation research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether treating atrial fibrillation (irregular heartbeat) early with a procedure called ablation can help prevent serious complications like strokes and heart failure, especially in people who have multiple other health conditions. The procedure uses a special catheter to safely restore a normal heart rhythm. Researchers believe this approach may work better than taking medications alone to control the irregular heartbeat.
Many people with irregular heartbeat still suffer strokes and heart complications even when taking blood thinners and other medications. This trial exists to see whether fixing the heart rhythm problem earlier with a procedure—rather than waiting and using only medications—can better protect patients, especially those dealing with multiple other health challenges.
You likely qualify if…
You likely don't qualify if…
If you are assigned to the early ablation group, you will receive a heart rhythm procedure designed to restore normal rhythm. If you are in the usual care group, you will continue your current heart medications and treatments. Both groups will be followed over time with regular visits and tests to track serious heart events like stroke, heart failure hospitalization, and death. The study aims to enroll 2,312 patients and will continue until enough major health events have occurred to answer the research question.
AI-generated summary from trial data · Jun 17, 2026 · Not medical advice
Australia
Canada
Germany
Netherlands
Poland